Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-21

Clinical Trial Update: A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab [Phase 2]

View source ↗

Summary

This document reports results from a Phase 2 pilot trial evaluating omalizumab for eosinophilic esophagitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xolair (omalizumab)

Snippet

Sponsor: University of Utah | Conditions: Esophagitis | Phase 2 | Status: COMPLETED | Results posted: 2013-10-21